HMP closes deal for MultiMedia Healthcare/Freedom

Share this article:

Malvern, Pa.-based HMP Communications, a privately held medical publishing and communications company, has acquired MultiMedia Healthcare/Freedom, a subsidiary of Freedom Communications Inc.

Financial terms of the transaction were not disclosed.

In a statement, HMP said the acquisition complements its wound care group and "will considerably increase its position in the geriatric marketplace, doubling its size within this market." The combined entity, operating under the name HMP Communications, increases the number of healthcare publications HMP produces to 12.

"This acquisition builds upon HMP's existing publications and services geared toward the aging population and complements HMP's offering across all company divisions," Charles Benaiah, president and chief operating officer of HMP Communications, said in the statement. "As we set out this year to build upon HMP's core capabilities, in MMHC we found a company with synergistic opportunities for growth. Following the acquisition, HMP will have increased its infrastructure and resources to best serve our customer base and our increased size positions HMP as a true leader in healthcare publishing across multiple disciplines."

HMP will acquire MMHC publications Clinical Geriatrics, a peer-reviewed journal focused on issues related to the diagnosis and management of long term care patients, and Annals of Long Term Care, a peer-reviewed medical journal focused on issues related to the treatment and management of the mature patient. In addition, MMHC provides a broad range of consultative communications services to pharmaceutical clients through its Programs in Medicine division, which complements HMPs's MedPro and NACCME divisions. HMP plans to maintain MMHC's Princeton office.

Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Channel

Email Newsletters

MM&M Future Leaders

Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...